Cognitive Behavioral Therapy for Painful Diabetic Neuropathy
CompletedNot applicableNCT00830011
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The primary objective of this study is to evaluate the usefulness of cognitive behavioral therapy (CBT) for the management of painful diabetic neuropathy. Participants will be randomly assigned to one of two treatment conditions: CBT plus standard medical care or standard medical care alone. CBT will be offered in ten, ninety-minute group sessions and will be provided by a psychologist with experience in the management of both diabetes and chronic pain. CBT will involve teaching and encouraging practice of adaptive pain coping skills such as relaxation skills, activity pacing, and positive self-statements, among others. This study will allow us to determine which treatment is superior in terms of improvements in pain management, functioning and overall quality of life.
Study details
- Official title
- Cognitive Behavioral Therapy for Painful Diabetic Neuropathy
- Conditions
- Diabetic Neuropathy
- Interventions
- Behavioral: cognitive behavioral therapy
- Other: standard medical care
- Sponsor
- VA Connecticut Healthcare System
- Collaborators
- Donaghue Medical Research Foundation
- Start date
- 2004-09
- Primary completion
- 2009-06
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Total sites listed
- 0
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * type 2 diabetes mellitus * daily lower extremity pain or discomfort (burning, tingling or other parasthesias) for at least 3 months * documented trial of at least one medication for neuropathic pain * pain of at least 4 on a 0-10 numeric rating scale Exclusion Criteria: * acute medical condition, substance abuse, or psychiatric condition that would impair ability to participate * dementia (MMSE score of 23 or lower)
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT00830011